| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.0B | $0.6B | $0.5B | $0.5B | $0.8B | $0.2B | $0.2B | $0.1B |
| Net Income | $0.8B | $0.4B | $0.4B | $0.3B | $0.6B | $0.2B | $0.1B | $0.1B |
| EPS (Basic) | $5.25 | $2.57 | $2.37 | $2.23 | $3.60 | $1.03 | $0.59 | $0.54 |
| EPS (Diluted) | $5.23 | $2.56 | $2.37 | $2.23 | $3.59 | $1.02 | $0.59 | $0.54 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.3B | $7.0B | $6.5B | $6.2B | $6.7B | $6.7B | $7.6B | $6.9B |
| Current Assets | $3.8B | $2.6B | $2.5B | $2.2B | $2.4B | $2.2B | $2.6B | $2.0B |
| Cash & Equivalents | $1.3B | $1.2B | $1.2B | — | — | — | — | — |
| Total Liabilities | $2.2B | $1.9B | $1.6B | $1.6B | $1.9B | $1.9B | $2.0B | $1.9B |
| Current Liabilities | $0.9B | $0.7B | $0.6B | $0.6B | $0.8B | $0.7B | $0.8B | $0.7B |
| Stockholders' Equity | $5.1B | $4.6B | $4.5B | $4.4B | $4.6B | $4.7B | $4.9B | $4.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.7B | $0.4B | $0.5B | $0.9B | $0.6B | $0.5B | $0.7B |
| Investing Cash Flow | $-0.5B | $-0.3B | $-0.3B | $0.1B | $-0.3B | $0.1B | $-0.4B | $0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.2B | $-0.3B | $-0.2B | $-0.4B | $-0.6B | $-0.5B | $-0.2B | $-0.6B |